Results for tag: "Novolin R"

Novolin R is a brand of recombinant human insulin used to treat endocrine and metabolic disorders. It is a short-acting insulin that is used to control high blood sugar levels in people with diabetes. Novolin R is administered subcutaneously, usually before meals, and works by helping the body use glucose more efficiently. It is also used to treat other endocrine and metabolic disorders, such as hyperglycemia, hypoglycemia, and hyperinsulinemia. Novolin R is available in both vials and pens, and is typically prescribed in combination with other diabetes medications. The Novolin R market is highly competitive, with a number of companies offering similar products. These include Novo Nordisk, Eli Lilly, Sanofi, Merck, and AstraZeneca. Each company offers a range of insulin products, including Novolin R, to meet the needs of patients with endocrine and metabolic disorders. Show Less Read more